PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Breast cancer is a highly heterogeneous disease comprising a variety of genotypes and phenotypes of varying levels of aggressiveness. This presents significant challenges to clinical management of early-stage cancers. In this paper, we describe the use of multimodal optical technologies including near-infrared (NIR) spectroscopy, diffuse correlation spectroscopy (DCS) and indocyanine green (ICG) fluorescence imaging to evaluate the aggressiveness and progression of two patient-derived xenograft models of human breast cancer. Optical markers reveal distinctive features between low- and high-aggressiveness tumors that could potentially be translated for clinical use.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Bin Deng, Ailis Muldoon, Rahul Pal, Alana W. Ross, Pamela Pantazopoulos, Zdravka O. Medarova, Anand T. N. Kumar, Stefan A. Carp, "Multimodal optical assessment of breast tumor aggressiveness and progression in murine models," Proc. SPIE 11634, Multimodal Biomedical Imaging XVI, 116340B (5 March 2021); https://doi.org/10.1117/12.2577699